Dupixent Leads for Pharma TV Ad Spend in October
Dupixent, Sanofi and Regeneron’s immunology drug, had the highest estimated TV ad spend of pharma brands in October, per data from iSpot.tv. It led the ranking with $42.6 million in TV ad spend, up from $29.4 million in September.
- Dupixent's biggest ticket ad was "Firefighter and Surfer" with an estimated outlay of $16.4 million.
- Rinvoq, which led for each of the previous three months, moved to second place with $41.7 million in estimated TV ad spend.
- Latuda, which previously had not been among the top ten, took third place with $22.6 million (up from $8.2 million in Sep.).
Get the full ranking and more pharmaceutical TV ad spend insights in this article from FiercePharma.